NOVACYT (ALNOV.PA) Stock Price, Forecast & Analysis

EPA:ALNOV • FR0010397232

0.389 EUR
0 (-0.26%)
Last: Feb 23, 2026, 07:00 PM

ALNOV.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap27.48M
Revenue(TTM)19.10M
Net Income(TTM)-30.40M
Shares70.63M
Float70.50M
52 Week High0.74
52 Week Low0.38
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.5
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2012-10-12
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
ALNOV.PA short term performance overview.The bars show the price performance of ALNOV.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

ALNOV.PA long term performance overview.The bars show the price performance of ALNOV.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of ALNOV.PA is 0.389 EUR. In the past month the price decreased by -11.59%. In the past year, price decreased by -34.84%.

NOVACYT / ALNOV Daily stock chart

ALNOV.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
ALNOV.PA Full Technical Analysis Report

ALNOV.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ALNOV.PA. While ALNOV.PA seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ALNOV.PA Full Fundamental Analysis Report

ALNOV.PA Financial Highlights

Over the last trailing twelve months ALNOV.PA reported a non-GAAP Earnings per Share(EPS) of -0.5. The EPS increased by 17.85% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -48.32%
ROE -74.44%
Debt/Equity 0.24
Chartmill High Growth Momentum
EPS Q2Q%61.73%
Sales Q2Q%-5.12%
EPS 1Y (TTM)17.85%
Revenue 1Y (TTM)8.5%
ALNOV.PA financials

ALNOV.PA Forecast & Estimates


Analysts
Analysts37.14
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
ALNOV.PA Analyst EstimatesALNOV.PA Analyst Ratings

ALNOV.PA Ownership

Ownership
Inst Owners0.05%
Ins Owners0.06%
Short Float %N/A
Short RatioN/A
ALNOV.PA Ownership

About ALNOV.PA

Company Profile

ALNOV logo image Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 234 full-time employees. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. The company offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.

Company Info

NOVACYT

131 Boulevard Carnot, Le Vesinet

Velizy-Villacoublay ILE-DE-FRANCE FR

Employees: 234

ALNOV Company Website

ALNOV Investor Relations

Phone: 33139465104

NOVACYT / ALNOV.PA FAQ

What does NOVACYT do?

Novacyt SAS is a diagnostics company, which engages in the business of developing, producing, and selling vitro and molecular diagnostic tests and products for a wide range of infectious diseases. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 234 full-time employees. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. The company offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.


Can you provide the latest stock price for NOVACYT?

The current stock price of ALNOV.PA is 0.389 EUR. The price decreased by -0.26% in the last trading session.


What is the dividend status of NOVACYT?

ALNOV.PA does not pay a dividend.


How is the ChartMill rating for NOVACYT?

ALNOV.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Which stock exchange lists ALNOV stock?

ALNOV.PA stock is listed on the Euronext Paris exchange.


Can you provide the sector and industry classification for NOVACYT?

NOVACYT (ALNOV.PA) operates in the Health Care sector and the Biotechnology industry.


Who owns NOVACYT?

You can find the ownership structure of NOVACYT (ALNOV.PA) on the Ownership tab.